Published in Int J STD AIDS on February 01, 2010
Homophobia, stigma and HIV in Jamaican prisons. Cult Health Sex (2011) 0.83
Intravaginal cleansing among women attending a sexually transmitted infection clinic in Kingston, Jamaica. West Indian Med J (2013) 0.82
HIV coping self-efficacy: a key to understanding stigma and HIV test acceptance among incarcerated men in Jamaica. AIDS Care (2010) 0.80
Routine testing for blood-borne viruses in prisons: a systematic review. Eur J Public Health (2015) 0.78
Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep (2006) 37.28
Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review. PLoS Med (2007) 7.94
Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. J Urban Health (2001) 6.03
HIV in prison in low-income and middle-income countries. Lancet Infect Dis (2007) 4.43
Male prisoners and HIV prevention: a call for action ignored. Am J Public Health (2003) 3.73
Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol (1994) 2.81
Epidemiology of male same-sex behaviour and associated sexual health indicators in low- and middle-income countries: 2003-2007 estimates. Sex Transm Infect (2008) 2.66
HIV among gay and other men who have sex with men in Latin America and the Caribbean: a hidden epidemic? AIDS (2002) 2.18
HIV transmission among male inmates in a state prison system--Georgia, 1992-2005. MMWR Morb Mortal Wkly Rep (2006) 1.77
HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin. Am J Public Health (1990) 1.74
Intraprison HIV transmission: an assessment of whether it occurs, how it occurs, and who is at risk. AIDS Educ Prev (2002) 1.73
Sex, drugs, prisons, and HIV. N Engl J Med (2007) 1.25
The HIV epidemic in the Caribbean: meeting the challenges of achieving universal access to prevention, treatment and care. West Indian Med J (2008) 1.16
HIV seroprevalence among male prison inmates in the Wisconsin Correctional System. WMJ (1998) 1.15
HIV testing in correctional institutions: evaluating existing strategies, setting new standards. AIDS Public Policy J (2007) 1.03
An overview of HIV/AIDS in Jamaica: strengthening the response. West Indian Med J (2004) 0.88
Revisiting the debate of voluntary versus mandatory HIV/AIDS testing in U.S. prisons. J Health Hum Serv Adm (1999) 0.82
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
Assessing gene significance from cDNA microarray expression data via mixed models. J Comput Biol (2001) 10.38
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet (1999) 10.28
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet (1997) 7.52
Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol (1993) 6.21
Multicenter evaluation of the BDProbeTec ET System for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens, female endocervical swabs, and male urethral swabs. J Clin Microbiol (2001) 4.92
Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA (1998) 4.12
Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44
Detection and analysis of diverse herpesviral species by consensus primer PCR. J Clin Microbiol (1996) 3.27
Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol (1998) 2.81
Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol (2000) 2.80
Selective and enhanced recovery of group A and B streptococci from throat cultures with sheep blood agar containing sulfamethoxazole and trimethoprim. J Clin Microbiol (1977) 2.80
Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med (1998) 2.78
Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis (1998) 2.60
Relationship of alcohol use and risky sexual behavior: a review and analysis of findings. J Adolesc Health (1996) 2.53
Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med (1998) 2.45
Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. J Clin Microbiol (1998) 2.35
Twice-weekly administration of peginterferon-alpha-2b improves viral kinetics in patients with chronic hepatitis C genotype 1. J Viral Hepat (2003) 2.33
Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet (1998) 2.29
Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer (1989) 2.24
Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis (1996) 2.12
Concurrent sex partners and risk for sexually transmitted diseases among adolescents. Sex Transm Dis (1999) 2.06
Detection and differentiation of Chlamydia trachomatis, Chlamydia psittaci, and Chlamydia pneumoniae by DNA amplification. J Infect Dis (1990) 1.98
Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells. Cancer Res (1989) 1.94
Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis (1995) 1.86
Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience (1997) 1.84
Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet (2000) 1.76
Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin. J Biol Chem (1991) 1.74
Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol (2001) 1.73
Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex Transm Infect (2003) 1.72
Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol (2012) 1.68
Attitudes about sexual disclosure and perceptions of stigma and shame. Sex Transm Infect (2002) 1.68
Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis (2001) 1.66
Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol (1991) 1.61
Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol (2000) 1.60
Restoration of junctional tetrads in dysgenic myotubes by dihydropyridine receptor cDNA. Biophys J (1994) 1.58
Screening for gonorrhea and chlamydia by DNA amplification in adolescents attending middle school health centers. Opportunity for early intervention. Sex Transm Dis (1998) 1.58
Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med (1989) 1.57
Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. Chest (1998) 1.57
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob Agents Chemother (1992) 1.56
Preference among female Army recruits for use of self-administrated vaginal swabs or urine to screen for Chlamydia trachomatis genital infections. Sex Transm Dis (2003) 1.53
Molecular diagnosis of Chlamydia pneumoniae infection. J Clin Microbiol (1999) 1.52
Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens. J Clin Microbiol (2001) 1.46
Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun (1995) 1.45
Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II. Biochemistry (1986) 1.39
Management of vaginal discharge in women treated at a Jamaican sexually transmitted disease clinic: use of diagnostic algorithms versus laboratory testing. Clin Infect Dis (1995) 1.37
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis (2000) 1.36
Human population expansion and microsatellite variation. Mol Biol Evol (2000) 1.34
Comparison of the Phadebact Gonococcus Test with the rapid fermentation method. J Clin Microbiol (1981) 1.34
A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer (1992) 1.33
Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro. Proc Natl Acad Sci U S A (1982) 1.33
The role of behavioral experience in judging risks. Health Psychol (2001) 1.33
Community-acquired pneumonia: impact of immune status. Am J Respir Crit Care Med (1995) 1.29
Lead poisoning among household members exposed to lead-acid battery repair shops in Kingston, Jamaica. Int J Epidemiol (1989) 1.29
Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. Sex Transm Dis (1999) 1.28
Determinants of adolescents' satisfaction with health care providers and intentions to keep follow-up appointments. J Adolesc Health (1998) 1.27
Absence of impact of aerial malathion treatment on Aedes aegypti during a dengue outbreak in Kingston, Jamaica. Rev Panam Salud Publica (1999) 1.25
Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci (2001) 1.24
Evaluation of a latex agglutination test for Clostridium difficile in two nursing home outbreaks. J Clin Microbiol (1989) 1.20
Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females. Sex Transm Infect (2001) 1.20
Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. J Infect Dis (2001) 1.19
Diagnosis of human papillomavirus infection by dry vaginal swabs in military women. Sex Transm Infect (2001) 1.17
DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators. Nucleic Acids Res (1987) 1.17
A high-resolution physical map of human chromosome 21p using yeast artificial chromosomes. Genome Res (1999) 1.16
Influence of endocervical specimen adequacy on PCR and direct fluorescent-antibody staining for detection of Chlamydia trachomatis infections. J Clin Microbiol (1997) 1.15
Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res (1991) 1.14
Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda. Sex Transm Infect (2008) 1.14
Experimental infection with Chlamydia pneumoniae in nonhuman primates. Infect Immun (1990) 1.13
Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat Genet (1998) 1.13
Pooling of urine samples for screening for Neisseria gonorrhoeae by ligase chain reaction: accuracy and application. J Clin Microbiol (1998) 1.12
Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticinium. Biochem Pharmacol (1982) 1.12
Sexual network position and risk of sexually transmitted infections. Sex Transm Infect (2009) 1.12
Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia. Free Radic Biol Med (2001) 1.12
Bot-fly bite. Postgrad Med J (1993) 1.11
Purification and identification of brain-derived neurotrophic factor from human serum. Protein Expr Purif (1995) 1.11
Recurrent meningococcemia associated with IgG2-subclass deficiency. N Engl J Med (1983) 1.11
Randomized controlled trial to investigate impact of site-based safer sex programmes in Kingston, Jamaica: trial design, methods and baseline findings. Trop Med Int Health (2008) 1.10
Shear vs pressure as causative factors in skin blood flow occlusion. Arch Phys Med Rehabil (1979) 1.10
[Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system]. Acta Diabetol Lat (1969) 1.08
Court-involved battered women's responses to violence: the role of psychological, physical, and sexual abuse. Violence Vict (1999) 1.08
Genital ulcers: etiology, clinical diagnosis, and associated human immunodeficiency virus infection in Kingston, Jamaica. Clin Infect Dis (1999) 1.08
Atherosclerosis in apoE knockout mice infected with multiple pathogens. J Infect Dis (2000) 1.08
Local understanding of an HIV vaccine and its relationship with HIV-related stigma in the Dominican Republic. AIDS Care (2007) 1.07
Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. II. Geographic and ecologic determinants. Am J Epidemiol (1991) 1.07
Characteristics of trichiasis patients presenting for surgery in rural Ethiopia. Br J Ophthalmol (2005) 1.07
Discussing childbearing with HIV-infected women of reproductive age in clinical care: a comparison of Brazil and the US. AIDS Behav (2012) 1.07
Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res (1986) 1.06
Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia (2002) 1.04
A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in Jamaica. Int J Epidemiol (1996) 1.04
Survey of persons with multiple sclerosis in Ottawa, 1974-75. Can J Public Health (1977) 1.04
Phosphorylation of mammalian DNA topoisomerase I and activation by protein kinase C. J Biol Chem (1990) 1.04
Inhibitors of poly-(adenosine diphosphoribose) synthesis slow the resealing rate of x-ray-induced DNA strand breaks. Biochem Biophys Res Commun (1982) 1.04
Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells. Cancer Res (1987) 1.04
Perceived STD risk, relationship, and health values in adolescents' delaying sexual intercourse with new partners. Sex Transm Infect (2004) 1.03
Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide. Cancer Res (1982) 1.02
Screening for sexually transmitted diseases and hepatitis in 18-29-year-old men recently released from prison: feasibility and acceptability. Int J STD AIDS (2005) 1.02
Use of lambda phage DNA as a hybrid internal control in a PCR-enzyme immunoassay to detect Chlamydia pneumoniae. J Clin Microbiol (1998) 1.02
NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression. Br J Cancer (2012) 1.01
The adequacy of reimbursement for HIV under Section 1115 Medicaid waivers. AIDS Public Policy J (1997) 1.01